Is It Time To Consider Buying DaVita Inc. (NYSE:DVA)?
Is It Time To Consider Buying DaVita Inc. (NYSE:DVA)?
DaVita Inc. (NYSE:DVA) led the NYSE gainers with a relatively large price hike in the past couple of weeks. The recent jump in the share price has meant that the company is trading at close to its 52-week high. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, what if the stock is still a bargain? Let's examine DaVita's valuation and outlook in more detail to determine if there's still a bargain opportunity.
DaVita Inc.(纽约证券交易所代码:DVA)在过去几周中以相对较大的价格上涨带动了纽约证券交易所的涨幅。最近股价的上涨意味着该公司的交易价格接近52周高点。由于许多分析师都在报道这只大盘股,我们可能预计,任何对价格敏感的公告都已计入该股的股价。但是,如果股票仍然很便宜怎么办?让我们更详细地研究一下DaVita的估值和前景,以确定是否还有讨价还价的机会。
Is DaVita Still Cheap?
DaVita 还便宜吗?
Good news, investors! DaVita is still a bargain right now according to our price multiple model, which compares the company's price-to-earnings ratio to the industry average. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. we find that DaVita's ratio of 17.12x is below its peer average of 22.68x, which indicates the stock is trading at a lower price compared to the Healthcare industry. Although, there may be another chance to buy again in the future. This is because DaVita's beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity.
好消息,投资者!根据我们的多价模型,DaVita目前仍然很划算,该模型将公司的市盈率与行业平均水平进行了比较。在这种情况下,鉴于没有足够的信息来可靠地预测股票的现金流,我们使用了市盈率(PE)。我们发现DaVita的17.12倍比率低于其同行平均水平的22.68倍,这表明该股票的交易价格低于医疗保健行业的交易价格。但是,将来可能会有另一次买入的机会。这是因为DaVita的beta(衡量股价波动的指标)很高,这意味着其价格相对于其他市场的价格走势将被夸大。如果市场看跌,该公司的股票下跌幅度可能会超过其他市场,这提供了绝佳的买入机会。
What does the future of DaVita look like?
DaVita的未来会是什么样子?
Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 41% over the next couple of years, the future seems bright for DaVita. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.
当你考虑买入股票时,未来前景是一个重要的方面,特别是如果你是寻求投资组合增长的投资者。尽管价值投资者会争辩说,最重要的是相对于价格的内在价值,但更有说服力的投资论点是以低廉的价格获得高增长潜力。预计未来几年利润将增长41%,DaVita的前景似乎一片光明。看来该股的现金流即将增加,这应该会促进更高的股票估值。
What This Means For You
这对你意味着什么
Are you a shareholder? Since DVA is currently below the industry PE ratio, it may be a great time to increase your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current price multiple.
你是股东吗?由于DVA目前低于行业市盈率,因此现在可能是增加股票持有量的好时机。随着乐观前景的临近,这种增长似乎尚未完全纳入股价。但是,还有其他因素需要考虑,例如资本结构,这可以解释当前的价格倍数。
Are you a potential investor? If you've been keeping an eye on DVA for a while, now might be the time to enter the stock. Its prosperous future profit outlook isn't fully reflected in the current share price yet, which means it's not too late to buy DVA. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision.
你是潜在的投资者吗?如果你关注DVA已有一段时间了,那么现在可能是进入股票的时候了。其繁荣的未来盈利前景尚未完全反映在当前的股价中,这意味着现在购买DVA还为时不晚。但是,在做出任何投资决策之前,请考虑其他因素,例如资产负债表的强度,以便做出明智的投资决策。
If you'd like to know more about DaVita as a business, it's important to be aware of any risks it's facing. For example - DaVita has 1 warning sign we think you should be aware of.
如果您想进一步了解DaVita作为一家企业,请务必了解其面临的任何风险。例如,DaVita 有 1 个警告标志,我们认为您应该注意。
If you are no longer interested in DaVita, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
如果您不再对DaVita感兴趣,可以使用我们的免费平台查看我们列出的其他50多只具有高增长潜力的股票清单。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。